# Grifols Therapeutics LLC – FDA Inspection, Oct 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9a41f385-bd40-454e-bfcf-1cf95a896584
Source feed: FDA_Inspections

> FDA inspection 994781 of Grifols Therapeutics LLC, October 21, 2016. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 994781
- Company Name: Grifols Therapeutics LLC
- Inspection Date: 2016-10-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1302186 - 2026-02-05](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/34708a56-41e8-4e87-bab0-c702d71a2713)
- [FDA Inspection 1221101 - 2023-09-01](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/8955f0eb-74f7-40f8-be3a-2ebaa64a50c8)
- [FDA Inspection 1176467 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9cf52920-d34b-4f87-840d-e52213631e5a)
- [FDA Inspection 1079999 - 2018-12-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a8c4df93-a1d3-415f-a6ee-5067a6f6675c)
- [FDA Inspection 1003199 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/cd7b9835-ca8b-4844-95da-18ed498be896)

## Related Officers

- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)
- [FDA Associated Person](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)

Company: https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d